<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02701283</url>
  </required_header>
  <id_info>
    <org_study_id>10234430Doc</org_study_id>
    <nct_id>NCT02701283</nct_id>
  </id_info>
  <brief_title>Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients</brief_title>
  <official_title>Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to demonstrate that the safety and effectiveness of the Medtronic TAVR&#xD;
      system as measured by rates of all-cause mortality or disabling stroke at two years is&#xD;
      noninferior to SAVR in the treatment of severe aortic stenosis in subjects who have a low&#xD;
      predicted risk of operative mortality for SAVR.&#xD;
&#xD;
      The purpose of the expanded use addendum to the Medtronic TAVR in Low Risk Patients Trial&#xD;
      protocol is to conclude the randomized phase of the trial and initiate the single-arm,&#xD;
      non-randomized, continued access phase of the trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-center, international, prospective, randomized, interventional, pre-market.&#xD;
&#xD;
      Subjects will be randomized on 1:1 basis to either TAVR with the Medtronic TAVR system or to&#xD;
      SAVR. Patients will be seen at pre and post-procedure, discharge, 30 days, 6 months, 1 year,&#xD;
      18 months, and annually through 10 years.&#xD;
&#xD;
      The expanded use addendum is a multi-center, prospective, non-randomized continued access&#xD;
      trial. All heart team approved subjects will be assigned to TAVR with the Medtronic TAVR&#xD;
      system. Patients will be seen at pre and post-procedure, discharge, 30 days, and annually&#xD;
      through 10 years. Enrollment is expected not to exceed 3660 attempted implants in the United&#xD;
      States.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2026</completion_date>
  <primary_completion_date type="Actual">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety: All Cause Mortality or Disabling Stroke Rate at 24 Months, Randomized Controlled Trial</measure>
    <time_frame>24 months</time_frame>
    <description>Assessment of procedural safety by:&#xD;
All-cause mortality: all deaths from any cause after valve intervention. This includes all cardiovascular and non-cardiovascular deaths.&#xD;
Disabling stroke: a modified rankin score (mRS) of 2 or more at 90 days post-stroke and an increase of at least one mRS category from an individual's pre-stroke baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of Death, Disabling Stroke, Life-threatening Bleed, Major Vascular Complication, or AKI (II or III) at 30 Days, Randomized Controlled Trial</measure>
    <time_frame>30 days</time_frame>
    <description>Combined clinical efficacy after 30 days was defined as the composite of all-cause mortality, disabling stroke, life-threatening bleed, major vascular complication, or AKI (II or III)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New Pacemaker Implantation at 30 Days, Randomized Controlled Trial</measure>
    <time_frame>30 days</time_frame>
    <description>The rate of new permanent pacemaker implant at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic Valve Endocarditis at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of prosthetic valve endocarditis at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic Valve Thrombosis at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of prosthetic valve thrombosis at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Stroke (Disabling and Non-disabling) at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of all stroke (disabling and non-disabling) at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life-threatening Bleeding at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of life-threatening bleeding at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valve-related Dysfunction Requiring Repeat Procedure at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of valve-related dysfunction requiring repeat procedure at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valve-related Dysfunction (Moderate or Severe Stenosis or Regurgitation) at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>Stenosis (moderate or severe)&#xD;
Any of the following:&#xD;
Peak aortic velocity &gt;4 m/s OR mean aortic gradient &gt;40 mmHg, AND EOA &lt;0.8 cm2&#xD;
Peak aortic velocity &gt;4 m/s OR mean aortic gradient &gt;40 mmHg, AND EOA ≥0.8 cm2, and DVI &lt;0.25&#xD;
Peak aortic velocity ≤4 m/s and mean aortic gradient ≤ 40 mmHg, AND EOA &lt;0.8 cm2, and DVI &lt;0.25&#xD;
Regurgitation (moderate or severe)&#xD;
Any of the following:&#xD;
Moderate or Severe Total Regurgitation&#xD;
Moderate or Severe Paravalvular Regurgitation&#xD;
Moderate or Severe Transvalvular Regurgitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life as Assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) at 30 Days and 1 Year, Randomized Controlled Trial</measure>
    <time_frame>30 days and 1 year</time_frame>
    <description>Quality of life summary scores and change from baseline using the following measures:&#xD;
KCCQ: Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat Hospitalization for Aortic Valve Disease at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of repeat hospitalization for aortic valve disease at 1 year</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hemodynamic Performance Metrics by Doppler Echocardiography: Percent of Participants With Degrees of Total Prosthetic Valve Regurgitation at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>Reporting of prosthetic valve hemodynamic performance by degree of total prosthetic valve regurgitation</description>
  </other_outcome>
  <other_outcome>
    <measure>Hemodynamic Performance Metrics by Doppler Echocardiography at 1 Year, Randomized Controlled Trial Effective Orifice Area (EOA) at 1 Year</measure>
    <time_frame>1 year</time_frame>
    <description>Reporting of prosthetic valve hemodynamic performance by EOA</description>
  </other_outcome>
  <other_outcome>
    <measure>Health-related Quality of Life as Assessed by European QoL (EQ-5D) at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>Quality of life summary scores and change from baseline using the following measures:&#xD;
EQ-5D: Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state</description>
  </other_outcome>
  <other_outcome>
    <measure>New York Heart Association (NYHA) Functional Classification at 1 Year, Randomized Controlled Trial</measure>
    <time_frame>1 year</time_frame>
    <description>Reporting of NYHA classification at 1 year&#xD;
NYHA Classification criteria:&#xD;
Class I: Subjects with cardiac disease but without resulting limitations of physical activity Class I: Subjects with cardiac disease resulting in slight limitation of physical activity Class III: Subjects with cardiac disease resulting in marked limitation of physical activity Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort</description>
  </other_outcome>
  <other_outcome>
    <measure>Hemodynamic Performance Metrics by Doppler Echocardiography at 1 Year, Randomized Controlled Trial Mean Aortic Gradient at 1 Year</measure>
    <time_frame>1 year</time_frame>
    <description>Reporting of prosthetic valve hemodynamic performance by transvalvular mean aortic gradient</description>
  </other_outcome>
  <other_outcome>
    <measure>Efficacy: Device Success Rate, Randomized Controlled Trial</measure>
    <time_frame>Hospital discharge or 7 days post-procedure (whichever occurs first)</time_frame>
    <description>Assessment of procedural effectiveness by meeting all of the following device success criteria:&#xD;
Absence of procedural mortality, AND&#xD;
Correct positioning of a single prosthetic heart valve into the proper anatomical location, AND&#xD;
Absence of moderate or severe total prosthetic valve regurgitation (at 18 hours to 7 days)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1478</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Medtronic Transcatheter Aortic Valve Replacement Systems</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of Aortic Stenosis with the Medtronic CoreValve System Transcatheter Aortic Valve Implantation (TAVI) device or the Medtronic Corevalve Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical Aortic Valve Replacement (SAVR)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment of Aortic Stenosis with commercial Surgical Aortic Valve Replacement (SAVR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic Transcatheter Aortic Valve Replacement Systems</intervention_name>
    <description>Treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR with Medtronic TAVR Systems</description>
    <arm_group_label>Medtronic Transcatheter Aortic Valve Replacement Systems</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgical Aortic Valve Replacement (SAVR)</intervention_name>
    <description>Treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR with a commercially approved surgical bioprothesis</description>
    <arm_group_label>Surgical Aortic Valve Replacement (SAVR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Severe aortic stenosis, defined as follows:&#xD;
&#xD;
               1. For symptomatic patients:&#xD;
&#xD;
                  Aortic valve area ≤1.0 cm2 (or aortic valve area index of ≤0.6 cm2/m2), OR mean&#xD;
                  gradient ≥40 mmHg, OR Maximal aortic valve velocity ≥4.0 m/sec by transthoracic&#xD;
                  echocardiography at rest&#xD;
&#xD;
               2. For asymptomatic patients:&#xD;
&#xD;
                    -  Very severe aortic stenosis with an aortic valve area of ≤1.0 cm2 (or aortic&#xD;
                       valve area index of ≤0.6 cm2/m2), AND maximal aortic velocity ≥5.0 m/sec ,&#xD;
                       or mean gradient ≥60 mmHg by transthoracic echocardiography at rest, OR&#xD;
&#xD;
                    -  Aortic valve area of ≤1.0 cm2 (or aortic valve area index of ≤0.6 cm2/m2),&#xD;
                       AND a mean gradient ≥40 mmHg or maximal aortic valve velocity ≥4.0 m/sec by&#xD;
                       transthoracic echocardiography at rest, AND an exercise tolerance test that&#xD;
                       demonstrates a limited exercise capacity, abnormal BP response, or&#xD;
                       arrhythmia OR&#xD;
&#xD;
                    -  Aortic valve area of ≤1.0 cm2 (or aortic valve area index of ≤0.6 cm2/m2),&#xD;
                       AND mean gradient ≥40 mmHg, or maximal aortic valve velocity ≥4.0 m/sec by&#xD;
                       transthoracic echocardiography at rest, AND a left ventricular ejection&#xD;
                       fraction &lt;50%.&#xD;
&#xD;
          2. Documented heart team agreement of low risk for SAVR, where low risk is defined as&#xD;
             predicted risk of mortality for SAVR &lt;3% at 30 days per multidisciplinary local heart&#xD;
             team assessment.&#xD;
&#xD;
          3. The subject and the treating physician agree that the subject will return for all&#xD;
             required post-procedure follow-up visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any condition considered a contraindication for placement of a bioprosthetic valve&#xD;
             (eg, subject is indicated for mechanical prosthetic valve).&#xD;
&#xD;
          2. A known hypersensitivity or contraindication to any of the following that cannot be&#xD;
             adequately pre-medicated:&#xD;
&#xD;
               1. aspirin or heparin (HIT/HITTS) and bivalirudin&#xD;
&#xD;
               2. ticlopidine and clopidogrel&#xD;
&#xD;
               3. Nitinol (titanium or nickel)&#xD;
&#xD;
               4. contrast media&#xD;
&#xD;
          3. Blood dyscrasias as defined: leukopenia (WBC &lt;1000 mm3), thrombocytopenia (platelet&#xD;
             count &lt;50,000 cells/mm3), history of bleeding diathesis or coagulopathy, or&#xD;
             hypercoagulable states.&#xD;
&#xD;
          4. Ongoing sepsis, including active endocarditis.&#xD;
&#xD;
          5. Any percutaneous coronary or peripheral interventional procedure with a bare metal&#xD;
             stent within 30 days prior to randomization, or drug eluting stent performed within&#xD;
             180 days prior to randomization.&#xD;
&#xD;
          6. Multivessel coronary artery disease with a Syntax score &gt;22 and/or unprotected left&#xD;
             main coronary artery.&#xD;
&#xD;
          7. Symptomatic carotid or vertebral artery disease or successful treatment of carotid&#xD;
             stenosis within 10 weeks of Heart Team assessment.&#xD;
&#xD;
          8. Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or&#xD;
             mechanical hemodynamic support.&#xD;
&#xD;
          9. Recent (within 2 months of Heart Team assessment) cerebrovascular accident (CVA) or&#xD;
             transient ischemic attack (TIA).&#xD;
&#xD;
         10. Gastrointestinal (GI) bleeding that would preclude anticoagulation.&#xD;
&#xD;
         11. Subject refuses a blood transfusion.&#xD;
&#xD;
         12. Severe dementia (resulting in either inability to provide informed consent for the&#xD;
             trial/procedure, prevents independent lifestyle outside of a chronic care facility, or&#xD;
             will fundamentally complicate rehabilitation from the procedure or compliance with&#xD;
             follow-up visits).&#xD;
&#xD;
         13. Estimated life expectancy of less than 24 months due to associated non-cardiac&#xD;
             co-morbid conditions.&#xD;
&#xD;
         14. Other medical, social, or psychological conditions that in the opinion of the&#xD;
             investigator precludes the subject from appropriate consent or adherence to the&#xD;
             protocol required follow-up exams.&#xD;
&#xD;
         15. Currently participating in an investigational drug or another device trial (excluding&#xD;
             registries).&#xD;
&#xD;
         16. Evidence of an acute myocardial infarction ≤30 days before the trial procedure due to&#xD;
             unstable coronary artery disease (WHO criteria).&#xD;
&#xD;
         17. Need for emergency surgery for any reason.&#xD;
&#xD;
         18. Subject is pregnant or breast feeding.&#xD;
&#xD;
         19. Subject is less than legal age of consent, legally incompetent, or otherwise&#xD;
             vulnerable&#xD;
&#xD;
         20. Pre-existing prosthetic heart valve in any position.&#xD;
&#xD;
         21. Severe mitral regurgitation amenable to surgical replacement or repair.&#xD;
&#xD;
         22. Severe tricuspid regurgitation amenable to surgical replacement or repair.&#xD;
&#xD;
         23. Moderate or severe mitral stenosis amenable to surgical replacement or repair.&#xD;
&#xD;
         24. Hypertrophic obstructive cardiomyopathy with left ventricular outflow gradient.&#xD;
&#xD;
         25. Bicuspid aortic valve verified by echocardiography, MDCT, or MRI.&#xD;
&#xD;
         26. Prohibitive left ventricular outflow tract calcification.&#xD;
&#xD;
         27. Sinus of Valsalva diameter unsuitable for placement of the self-expanding&#xD;
             bioprosthesis.&#xD;
&#xD;
         28. Aortic annulus diameter of &lt;18 or &gt;30 mm.&#xD;
&#xD;
         29. Significant aortopathy requiring ascending aortic replacement.&#xD;
&#xD;
             For transfemoral or transaxillary (subclavian) access:&#xD;
&#xD;
         30. Access vessel mean diameter &lt;5.0 mm for Evolut 23R, 26R, or 29R mm TAV, or access&#xD;
             vessel mean diameter &lt;5.5 mm for Evolut 34R mm or Evolut PRO TAV. However, for&#xD;
             transaxillary (subclavian) access in patients with a patent LIMA, access vessel mean&#xD;
             diameter &lt;5.5mm for Evolut 23R, 26R, or 29R mm TAV, or access vessel mean diameter&#xD;
             &lt;6.0 mm for the Evolut 34R or Evolut PRO TAV.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Reardon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Methodist Hospital Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John K. Forrest, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale New Haven Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abrazo Arizona Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Memorial Hospital La Jolla</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southern California University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>64040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Los Robles Hospital &amp; Medical Center</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delray Medical Center</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthPark Medical Center</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tallahassee Research Institute, Inc.</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Atlanta Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Heart Center of Indiana</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewish Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terrebonne General Medical Center</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Francis Hospital</name>
      <address>
        <city>East Hills</city>
        <state>New York</state>
        <zip>11548</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital Health Center</name>
      <address>
        <city>Liverpool</city>
        <state>New York</state>
        <zip>13088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strong Memorial Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OhioHealth Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integris Baptist Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geinsinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center UPMC Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Jack and Jane Hamilton Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Saint Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Salt Lake City Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Mary's Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paramount Heart</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Saint Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent's Hospital Sydney</name>
      <address>
        <city>Darlinghurst</city>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital (FSH)</name>
      <address>
        <city>Murdoch</city>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto General Health Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>MSG2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glen Royal Victoria (McGill)</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart</name>
      <address>
        <city>Montréal</city>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IUCPQ</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L'Hôpital Privé Jacques Cartier Massy</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kokura Memorial Hospital</name>
      <address>
        <city>Kitakyushu</city>
        <state>Fokuoka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Higashi Tokushukai Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Teikyo University Hospital</name>
      <address>
        <city>Tokyo</city>
        <state>Itabashi-K</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shonan Kamakura General Hospital</name>
      <address>
        <city>Kamakura</city>
        <state>Kanagawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sendai Kousei Hospital</name>
      <address>
        <city>Sendai</city>
        <state>Miyagi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cerebral and Cardiovasclular Center</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>565-8565</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka University Hospital</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sakakibara Heart Institute</name>
      <address>
        <city>Fuchu</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital Nieuwegein</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medisch Centrum</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital</name>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>France</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Switzerland</country>
  </removed_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <results_first_submitted>July 7, 2021</results_first_submitted>
  <results_first_submitted_qc>September 7, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 9, 2021</results_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 16, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT02701283/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 17, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT02701283/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Randomized Controlled Trial - As Treated</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Medtronic TAVR Systems</title>
          <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
        </group>
        <group group_id="P2">
          <title>SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="737"/>
                <participants group_id="P2" count="741"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>As Treated (Attempted Implant)</title>
              <participants_list>
                <participants group_id="P1" count="730"/>
                <participants group_id="P2" count="684"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Implanted</title>
              <participants_list>
                <participants group_id="P1" count="727"/>
                <participants group_id="P2" count="686"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="668"/>
                <participants group_id="P2" count="579"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="162"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missed 2-year visit</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Medtronic TAVR Systems</title>
          <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
        </group>
        <group group_id="B2">
          <title>SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="730"/>
            <count group_id="B2" value="684"/>
            <count group_id="B3" value="1414"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Subject age reported in years, Randomized Controlled Trial</description>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.1" spread="5.8"/>
                    <measurement group_id="B2" value="73.7" spread="5.9"/>
                    <measurement group_id="B3" value="73.9" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="266"/>
                    <measurement group_id="B2" value="233"/>
                    <measurement group_id="B3" value="499"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="464"/>
                    <measurement group_id="B2" value="451"/>
                    <measurement group_id="B3" value="915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Subject characteristic - subject age, Randomized Controlled Trial</title>
          <description>Subject age reported in years</description>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.1" spread="5.8"/>
                    <measurement group_id="B2" value="73.7" spread="5.9"/>
                    <measurement group_id="B3" value="73.9" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Subject characteristic - body surface area, Randomized Controlled Trial</title>
          <description>Calculated surface area of the human body in m^2</description>
          <units>m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.0" spread="0.2"/>
                    <measurement group_id="B2" value="2.0" spread="0.2"/>
                    <measurement group_id="B3" value="2.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Subject characteristic - SYNTAX Score I, Randomized Controlled Trial</title>
          <description>SYNTAX Score I is a tool used to calculate the complexity of coronary artery disease Minimum score: 0 Maximum score: 21 Higher values represent more complex coronary artery disease</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.9" spread="3.7"/>
                    <measurement group_id="B2" value="2.1" spread="3.9"/>
                    <measurement group_id="B3" value="2.0" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Society of Thoracic Surgeons (STS) score, Randomized Controlled Trial</title>
          <description>STS score is the of predicted risk of mortality at 30-days Minimum score: 0 Maximum score: 5 Higher values represent a higher risk of mortality at 30-days</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.0" spread="0.7"/>
                    <measurement group_id="B2" value="1.9" spread="0.7"/>
                    <measurement group_id="B3" value="1.9" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>STS factors, Randomized Controlled Trial</title>
          <description>Subject characteristics used to calculate STS score</description>
          <units>Percent of participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>STS Factors Diabetes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.4"/>
                    <measurement group_id="B2" value="30.7"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Serum Creatinine &gt;2 mg/dl</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.4"/>
                    <measurement group_id="B2" value="0.1"/>
                    <measurement group_id="B3" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Dialysis</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.0"/>
                    <measurement group_id="B2" value="0.1"/>
                    <measurement group_id="B3" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Hypertension</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84.8"/>
                    <measurement group_id="B2" value="82.4"/>
                    <measurement group_id="B3" value="83.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Endocarditis</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.0"/>
                    <measurement group_id="B2" value="0.0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Chronic Lung Disease (COPD)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.1"/>
                    <measurement group_id="B2" value="18.0"/>
                    <measurement group_id="B3" value="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Immunosuppressive Therapy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.1"/>
                    <measurement group_id="B2" value="1.0"/>
                    <measurement group_id="B3" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Peripheral Arterial Disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.5"/>
                    <measurement group_id="B2" value="8.2"/>
                    <measurement group_id="B3" value="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Cerebrovascular Disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.1"/>
                    <measurement group_id="B2" value="12.0"/>
                    <measurement group_id="B3" value="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Previous CABG</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.5"/>
                    <measurement group_id="B2" value="2.0"/>
                    <measurement group_id="B3" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Previous Valve Surgery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.0"/>
                    <measurement group_id="B2" value="0.0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Previous PCI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.1"/>
                    <measurement group_id="B2" value="12.9"/>
                    <measurement group_id="B3" value="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Previous MI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.6"/>
                    <measurement group_id="B2" value="4.8"/>
                    <measurement group_id="B3" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STS Factors Atrial Fibrillation/ Atrial Flutter</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.3"/>
                    <measurement group_id="B2" value="14.4"/>
                    <measurement group_id="B3" value="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association Classification, Randomized Controlled Trial</title>
          <description>New York Heart Association (NYHA) Classification:&#xD;
Class I: Subjects with cardiac disease but without resulting limitations of physical activity Class II: Subjects with cardiac disease resulting in slight limitation of physical activity Class III: Subjects with cardiac disease resulting in marked limitation of physical activity Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort</description>
          <units>Percent of participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>NYHA I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.4"/>
                    <measurement group_id="B2" value="9.2"/>
                    <measurement group_id="B3" value="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA II</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.7"/>
                    <measurement group_id="B2" value="62.6"/>
                    <measurement group_id="B3" value="63.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA III</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.8"/>
                    <measurement group_id="B2" value="27.8"/>
                    <measurement group_id="B3" value="26.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA IV</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.1"/>
                    <measurement group_id="B2" value="0.4"/>
                    <measurement group_id="B3" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Subject heart conduction disturbances, Randomized Controlled Trial</title>
          <description>Pre-existing permanent pacemaker or defibrillator: Subject is implanted with a permanent pacemaker or defibrillator at baseline</description>
          <units>Percent of participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.3"/>
                    <measurement group_id="B2" value="3.8"/>
                    <measurement group_id="B3" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Rankin Score (mRS), Randomized Controlled Trial</title>
          <description>mRS 0: No symptoms mRs 1: No significant disability despite symptoms; able to carry out usual duties and activities.&#xD;
mRS 2: Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance.&#xD;
mRS 3: Moderate disability; requiring some help, but able to walk without. assistance.&#xD;
mRS 4: Moderately severe disability; unable to walk without assistance and unable to attend to own bodily functions.&#xD;
mRS 5: Severe disability; bedridden, incontinent and requiring constant nursing care and attention mRS 6: Dead</description>
          <units>Percent of participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>mRS 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.8"/>
                    <measurement group_id="B2" value="85.0"/>
                    <measurement group_id="B3" value="84.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mRS1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.6"/>
                    <measurement group_id="B2" value="8.1"/>
                    <measurement group_id="B3" value="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mRS 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.6"/>
                    <measurement group_id="B2" value="6.2"/>
                    <measurement group_id="B3" value="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mRS 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.0"/>
                    <measurement group_id="B2" value="0.7"/>
                    <measurement group_id="B3" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mRS 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.0"/>
                    <measurement group_id="B2" value="0.0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mRS 5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.0"/>
                    <measurement group_id="B2" value="0.0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mRS 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.0"/>
                    <measurement group_id="B2" value="0.0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean aortic gradient, Randomized Controlled Trial</title>
          <description>Site reported mean aortic gradient in mmHg recorded at baseline</description>
          <units>mmHG</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.9" spread="12.2"/>
                    <measurement group_id="B2" value="46.5" spread="12.2"/>
                    <measurement group_id="B3" value="46.7" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Max aortic valve velocity, Randomized Controlled Trial</title>
          <description>Site reported maximum aortic valve velocity measured in m/sec</description>
          <units>m/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.4" spread="0.5"/>
                    <measurement group_id="B2" value="4.4" spread="0.5"/>
                    <measurement group_id="B3" value="4.4" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Aortic valve area (AVA), Randomized Controlled Trial</title>
          <description>Site reported aortic valve area measured in cm^2</description>
          <units>cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8" spread="0.2"/>
                    <measurement group_id="B2" value="0.8" spread="0.2"/>
                    <measurement group_id="B3" value="0.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular Ejection Fraction (LVEF), Randomized Controlled Trial</title>
          <description>Site reported LVEF measured is the percent of the blood ejected by the left ventricle when contracting</description>
          <units>Percentage of blood ejected</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="730"/>
                    <count group_id="B2" value="684"/>
                    <count group_id="B3" value="1414"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.7" spread="7.9"/>
                    <measurement group_id="B2" value="61.9" spread="7.7"/>
                    <measurement group_id="B3" value="61.8" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Safety: All Cause Mortality or Disabling Stroke Rate at 24 Months, Randomized Controlled Trial</title>
        <description>Assessment of procedural safety by:&#xD;
All-cause mortality: all deaths from any cause after valve intervention. This includes all cardiovascular and non-cardiovascular deaths.&#xD;
Disabling stroke: a modified rankin score (mRS) of 2 or more at 90 days post-stroke and an increase of at least one mRS category from an individual's pre-stroke baseline.</description>
        <time_frame>24 months</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Safety: All Cause Mortality or Disabling Stroke Rate at 24 Months, Randomized Controlled Trial</title>
          <description>Assessment of procedural safety by:&#xD;
All-cause mortality: all deaths from any cause after valve intervention. This includes all cardiovascular and non-cardiovascular deaths.&#xD;
Disabling stroke: a modified rankin score (mRS) of 2 or more at 90 days post-stroke and an increase of at least one mRS category from an individual's pre-stroke baseline.</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3"/>
                    <measurement group_id="O2" value="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Primary Hypothesis: TAVR with the Medtronic TAVR system is non-inferior to SAVR for all-cause mortality or disabling stroke rate during a fixed follow-up of 24 months for the Randomized Controlled Trial</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Absolute non-inferiority margin was 0.06</non_inferiority_desc>
            <param_type>Posterior Median of the Difference</param_type>
            <param_value>0.999</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>95% Bayesian credible interval for the difference (TAVR-SAVR) was (-4.4%, 0.4%). The 95% credible interval is the 2.5th and 97.5th percentiles of the posterior distribution.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Death, Disabling Stroke, Life-threatening Bleed, Major Vascular Complication, or AKI (II or III) at 30 Days, Randomized Controlled Trial</title>
        <description>Combined clinical efficacy after 30 days was defined as the composite of all-cause mortality, disabling stroke, life-threatening bleed, major vascular complication, or AKI (II or III)</description>
        <time_frame>30 days</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Death, Disabling Stroke, Life-threatening Bleed, Major Vascular Complication, or AKI (II or III) at 30 Days, Randomized Controlled Trial</title>
          <description>Combined clinical efficacy after 30 days was defined as the composite of all-cause mortality, disabling stroke, life-threatening bleed, major vascular complication, or AKI (II or III)</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Composite event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3"/>
                    <measurement group_id="O2" value="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                    <measurement group_id="O2" value="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Disabling stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                    <measurement group_id="O2" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Life-threatening or disabling bleed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5"/>
                    <measurement group_id="O2" value="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major vascular complication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7"/>
                    <measurement group_id="O2" value="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AKI (II or III)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8"/>
                    <measurement group_id="O2" value="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>New Pacemaker Implantation at 30 Days, Randomized Controlled Trial</title>
        <description>The rate of new permanent pacemaker implant at 30 days</description>
        <time_frame>30 days</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>New Pacemaker Implantation at 30 Days, Randomized Controlled Trial</title>
          <description>The rate of new permanent pacemaker implant at 30 days</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.7"/>
                    <measurement group_id="O2" value="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prosthetic Valve Endocarditis at 1 Year, Randomized Controlled Trial</title>
        <description>The rate of prosthetic valve endocarditis at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Prosthetic Valve Endocarditis at 1 Year, Randomized Controlled Trial</title>
          <description>The rate of prosthetic valve endocarditis at 1 year</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1"/>
                    <measurement group_id="O2" value="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prosthetic Valve Thrombosis at 1 Year, Randomized Controlled Trial</title>
        <description>The rate of prosthetic valve thrombosis at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Prosthetic Valve Thrombosis at 1 Year, Randomized Controlled Trial</title>
          <description>The rate of prosthetic valve thrombosis at 1 year</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3"/>
                    <measurement group_id="O2" value="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Stroke (Disabling and Non-disabling) at 1 Year, Randomized Controlled Trial</title>
        <description>The rate of all stroke (disabling and non-disabling) at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>All Stroke (Disabling and Non-disabling) at 1 Year, Randomized Controlled Trial</title>
          <description>The rate of all stroke (disabling and non-disabling) at 1 year</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3"/>
                    <measurement group_id="O2" value="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Life-threatening Bleeding at 1 Year, Randomized Controlled Trial</title>
        <description>The rate of life-threatening bleeding at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Life-threatening Bleeding at 1 Year, Randomized Controlled Trial</title>
          <description>The rate of life-threatening bleeding at 1 year</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                    <measurement group_id="O2" value="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Valve-related Dysfunction Requiring Repeat Procedure at 1 Year, Randomized Controlled Trial</title>
        <description>The rate of valve-related dysfunction requiring repeat procedure at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Valve-related Dysfunction Requiring Repeat Procedure at 1 Year, Randomized Controlled Trial</title>
          <description>The rate of valve-related dysfunction requiring repeat procedure at 1 year</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6"/>
                    <measurement group_id="O2" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Valve-related Dysfunction (Moderate or Severe Stenosis or Regurgitation) at 1 Year, Randomized Controlled Trial</title>
        <description>Stenosis (moderate or severe)&#xD;
Any of the following:&#xD;
Peak aortic velocity &gt;4 m/s OR mean aortic gradient &gt;40 mmHg, AND EOA &lt;0.8 cm2&#xD;
Peak aortic velocity &gt;4 m/s OR mean aortic gradient &gt;40 mmHg, AND EOA ≥0.8 cm2, and DVI &lt;0.25&#xD;
Peak aortic velocity ≤4 m/s and mean aortic gradient ≤ 40 mmHg, AND EOA &lt;0.8 cm2, and DVI &lt;0.25&#xD;
Regurgitation (moderate or severe)&#xD;
Any of the following:&#xD;
Moderate or Severe Total Regurgitation&#xD;
Moderate or Severe Paravalvular Regurgitation&#xD;
Moderate or Severe Transvalvular Regurgitation</description>
        <time_frame>1 year</time_frame>
        <population>Implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Valve-related Dysfunction (Moderate or Severe Stenosis or Regurgitation) at 1 Year, Randomized Controlled Trial</title>
          <description>Stenosis (moderate or severe)&#xD;
Any of the following:&#xD;
Peak aortic velocity &gt;4 m/s OR mean aortic gradient &gt;40 mmHg, AND EOA &lt;0.8 cm2&#xD;
Peak aortic velocity &gt;4 m/s OR mean aortic gradient &gt;40 mmHg, AND EOA ≥0.8 cm2, and DVI &lt;0.25&#xD;
Peak aortic velocity ≤4 m/s and mean aortic gradient ≤ 40 mmHg, AND EOA &lt;0.8 cm2, and DVI &lt;0.25&#xD;
Regurgitation (moderate or severe)&#xD;
Any of the following:&#xD;
Moderate or Severe Total Regurgitation&#xD;
Moderate or Severe Paravalvular Regurgitation&#xD;
Moderate or Severe Transvalvular Regurgitation</description>
          <population>Implanted</population>
          <units>Percent of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="686"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Moderate or severe stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                    <measurement group_id="O2" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate or severe regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3"/>
                    <measurement group_id="O2" value="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health-related Quality of Life as Assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) at 30 Days and 1 Year, Randomized Controlled Trial</title>
        <description>Quality of life summary scores and change from baseline using the following measures:&#xD;
KCCQ: Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
        <time_frame>30 days and 1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Health-related Quality of Life as Assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) at 30 Days and 1 Year, Randomized Controlled Trial</title>
          <description>Quality of life summary scores and change from baseline using the following measures:&#xD;
KCCQ: Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
          <population>As treated set</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day KCCQ - Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.6" spread="14.2"/>
                    <measurement group_id="O2" value="78.7" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day change from baseline - Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" spread="21.1"/>
                    <measurement group_id="O2" value="9.2" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day KCCQ - Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7" spread="13.4"/>
                    <measurement group_id="O2" value="82.6" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day change from baseline - Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4" spread="19.6"/>
                    <measurement group_id="O2" value="7.5" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year KCCQ - Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.6" spread="12.7"/>
                    <measurement group_id="O2" value="90.5" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year change from baseline - Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6" spread="20.6"/>
                    <measurement group_id="O2" value="20.7" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year KCCQ - Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.9" spread="13.4"/>
                    <measurement group_id="O2" value="90.2" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year change from baseline - Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.3" spread="18.9"/>
                    <measurement group_id="O2" value="14.8" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Repeat Hospitalization for Aortic Valve Disease at 1 Year, Randomized Controlled Trial</title>
        <description>The rate of repeat hospitalization for aortic valve disease at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Repeat Hospitalization for Aortic Valve Disease at 1 Year, Randomized Controlled Trial</title>
          <description>The rate of repeat hospitalization for aortic valve disease at 1 year</description>
          <population>As treated set</population>
          <units>Percent of participants (K-M rate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5"/>
                    <measurement group_id="O2" value="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Hemodynamic Performance Metrics by Doppler Echocardiography: Percent of Participants With Degrees of Total Prosthetic Valve Regurgitation at 1 Year, Randomized Controlled Trial</title>
        <description>Reporting of prosthetic valve hemodynamic performance by degree of total prosthetic valve regurgitation</description>
        <time_frame>1 year</time_frame>
        <population>Implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Hemodynamic Performance Metrics by Doppler Echocardiography: Percent of Participants With Degrees of Total Prosthetic Valve Regurgitation at 1 Year, Randomized Controlled Trial</title>
          <description>Reporting of prosthetic valve hemodynamic performance by degree of total prosthetic valve regurgitation</description>
          <population>Implanted</population>
          <units>Percent of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="686"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.4"/>
                    <measurement group_id="O2" value="72.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5"/>
                    <measurement group_id="O2" value="19.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild/Mild to Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.9"/>
                    <measurement group_id="O2" value="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate/Moderate to Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1"/>
                    <measurement group_id="O2" value="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1"/>
                    <measurement group_id="O2" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Hemodynamic Performance Metrics by Doppler Echocardiography at 1 Year, Randomized Controlled Trial Effective Orifice Area (EOA) at 1 Year</title>
        <description>Reporting of prosthetic valve hemodynamic performance by EOA</description>
        <time_frame>1 year</time_frame>
        <population>Implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Hemodynamic Performance Metrics by Doppler Echocardiography at 1 Year, Randomized Controlled Trial Effective Orifice Area (EOA) at 1 Year</title>
          <description>Reporting of prosthetic valve hemodynamic performance by EOA</description>
          <population>Implanted</population>
          <units>cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="686"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.23" spread="0.63"/>
                    <measurement group_id="O2" value="1.96" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Health-related Quality of Life as Assessed by European QoL (EQ-5D) at 1 Year, Randomized Controlled Trial</title>
        <description>Quality of life summary scores and change from baseline using the following measures:&#xD;
EQ-5D: Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Health-related Quality of Life as Assessed by European QoL (EQ-5D) at 1 Year, Randomized Controlled Trial</title>
          <description>Quality of life summary scores and change from baseline using the following measures:&#xD;
EQ-5D: Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state</description>
          <population>As treated set</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>EQ-5D Index Score at 1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" spread="0.21"/>
                    <measurement group_id="O2" value="0.81" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year change from baseline EQ-5D Index Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.24"/>
                    <measurement group_id="O2" value="0.08" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>New York Heart Association (NYHA) Functional Classification at 1 Year, Randomized Controlled Trial</title>
        <description>Reporting of NYHA classification at 1 year&#xD;
NYHA Classification criteria:&#xD;
Class I: Subjects with cardiac disease but without resulting limitations of physical activity Class I: Subjects with cardiac disease resulting in slight limitation of physical activity Class III: Subjects with cardiac disease resulting in marked limitation of physical activity Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort</description>
        <time_frame>1 year</time_frame>
        <population>As treated set</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>New York Heart Association (NYHA) Functional Classification at 1 Year, Randomized Controlled Trial</title>
          <description>Reporting of NYHA classification at 1 year&#xD;
NYHA Classification criteria:&#xD;
Class I: Subjects with cardiac disease but without resulting limitations of physical activity Class I: Subjects with cardiac disease resulting in slight limitation of physical activity Class III: Subjects with cardiac disease resulting in marked limitation of physical activity Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort</description>
          <population>As treated set</population>
          <units>Percent of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NYHA Class I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.6"/>
                    <measurement group_id="O2" value="79.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA Class II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.8"/>
                    <measurement group_id="O2" value="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA Class III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                    <measurement group_id="O2" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA Class IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                    <measurement group_id="O2" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Died prior to visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1"/>
                    <measurement group_id="O2" value="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Hemodynamic Performance Metrics by Doppler Echocardiography at 1 Year, Randomized Controlled Trial Mean Aortic Gradient at 1 Year</title>
        <description>Reporting of prosthetic valve hemodynamic performance by transvalvular mean aortic gradient</description>
        <time_frame>1 year</time_frame>
        <population>Implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Hemodynamic Performance Metrics by Doppler Echocardiography at 1 Year, Randomized Controlled Trial Mean Aortic Gradient at 1 Year</title>
          <description>Reporting of prosthetic valve hemodynamic performance by transvalvular mean aortic gradient</description>
          <population>Implanted</population>
          <units>mmHG</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="686"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.74" spread="3.58"/>
                    <measurement group_id="O2" value="11.27" spread="4.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Efficacy: Device Success Rate, Randomized Controlled Trial</title>
        <description>Assessment of procedural effectiveness by meeting all of the following device success criteria:&#xD;
Absence of procedural mortality, AND&#xD;
Correct positioning of a single prosthetic heart valve into the proper anatomical location, AND&#xD;
Absence of moderate or severe total prosthetic valve regurgitation (at 18 hours to 7 days)</description>
        <time_frame>Hospital discharge or 7 days post-procedure (whichever occurs first)</time_frame>
        <population>Implanted set. Per the Clinical Investigational Plan, the incidence estimate is provided for the TAVR group only.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic TAVR Systems</title>
            <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
          </group>
        </group_list>
        <measure>
          <title>Efficacy: Device Success Rate, Randomized Controlled Trial</title>
          <description>Assessment of procedural effectiveness by meeting all of the following device success criteria:&#xD;
Absence of procedural mortality, AND&#xD;
Correct positioning of a single prosthetic heart valve into the proper anatomical location, AND&#xD;
Absence of moderate or severe total prosthetic valve regurgitation (at 18 hours to 7 days)</description>
          <population>Implanted set. Per the Clinical Investigational Plan, the incidence estimate is provided for the TAVR group only.</population>
          <units>Percent of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.3" lower_limit="82.1" upper_limit="88.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected from study enrollment through the 24 month follow-up visit. Adverse event data are currently available and reported for up to 24 months for the Randomized Controlled Trial.</time_frame>
      <desc>All new or worsening AEs were collected through 24 months. After 24 months only serious and device-related events will be collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>Medtronic TAVR Systems</title>
          <description>Treatment with Medtronic CoreValve, Evolut R, and Evolut PRO systems</description>
        </group>
        <group group_id="E2">
          <title>SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="459" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="495" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="60" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Blood Loss Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Disseminated Intravascular Coagulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Heparin-Induced Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypergammaglobulinaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired Cardiac Septal Defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Acute Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Valve Calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arteriospasm Coronary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="135" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrial Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrial Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" subjects_affected="89" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block First Degree</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Second Degree</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrioventricular Dissociation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bundle Branch Block Left</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bundle Branch Block Right</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Conduction Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coronary Artery Dissection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coronary Ostial Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Diastolic Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dressler's Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Left Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Left Ventricular Hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Low Cardiac Output Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mitral Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Myocardial Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Nodal Rhythm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Paroxysmal Atrioventricular Block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pericardial Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pleuropericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Prosthetic Cardiac Valve Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pulseless Electrical Activity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Right Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Sinus Arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Sinus Node Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tricuspid Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ventricular Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertrophic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Meniere's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Adrenal Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thyroid Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cataract Nuclear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Corneal Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Macular Hole</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Macular Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Optic Ischaemic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Retinal Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Retinal Vein Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ulcerative Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Visual Impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vitreous Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Abdominal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Abdominal Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Abdominal Wall Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Acquired Oesophageal Web</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Appendiceal Mucocoele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Barrett's Oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dental Caries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Enterocolitis Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Faeces Discoloured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gastric Polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Angiectasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gingival Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hiatus Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Impaired Gastric Emptying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Incarcerated Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Large Intestinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Large Intestine Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Large Intestine Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lower Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mesenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Obstructive Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oesophageal Motility Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oesophageal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oesophageal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Rectal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Critical Illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Embolisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Extravasation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Generalised Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Granuloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Infusion Site Extravasation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Multiple Organ Dysfunction Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pelvic Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Puncture Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Stent-Graft Endoleak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Systemic Inflammatory Response Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Stent Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Hepatic Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cholecystitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gallbladder Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hepatic Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hepatocellular Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ischaemic Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arthritis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arthritis Infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bartholin's Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Biliary Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Brain Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Chronic Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Clostridium Difficile Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coccidioidomycosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Related Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Enterococcal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Escherichia Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Groin Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Implant Site Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lyme Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oral Candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Osteomyelitis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pseudomonas Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Skin Graft Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Staphylococcal Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Streptococcal Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Access Site Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Anaemia Postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arterial Injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Central Nervous System Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cervical Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Clavicle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Compression Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Craniocerebral Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Foreign Body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Foreign Body In Gastrointestinal Tract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Heart Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Incision Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Incision Site Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Incisional Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Meniscus Injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Metaphyseal Corner Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Periprocedural Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Phrenic Nerve Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pneumothorax Traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Post Procedural Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Post Procedural Fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Post Procedural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Post Procedural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Post Procedural Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postoperative Delirium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postoperative Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postoperative Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postoperative Thoracic Procedure Complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postpericardiotomy Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Procedural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Procedural Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Procedural Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Radiation Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Radiation Retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Radius Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Skin Abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Skin Laceration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Spinal Compression Fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Spinal Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Subdural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Subdural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Suture Related Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Toxicity To Various Agents</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ulna Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Upper Limb Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urethral Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Access Site Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Access Site Dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Access Site Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Access Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Graft Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vasoplegia Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Wound Secretion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Anticoagulation Drug Level Above Therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Blood Magnesium Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Brain Natriuretic Peptide Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>C-Reactive Protein Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Output Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Computerised Tomogram Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Echocardiogram Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ejection Fraction Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Electrocardiogram Qrs Complex Prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haemoglobin Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Heart Rate Irregular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Liver Function Test Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mammogram Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Occult Blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Red Blood Cell Analysis Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Transvalvular Pressure Gradient Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Troponin Increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urine Output Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Resistance Systemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Wall Motion Score Index Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Body Fat Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Failure To Thrive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Fluid Overload</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypervolaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lactic Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Metabolic Alkalosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vitamin B12 Deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Chest Wall Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Flank Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Foot Deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Groin Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Displacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Polymyalgia Rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Rotator Cuff Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Spinal Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Trigger Finger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute Myeloid Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Adenoid Cystic Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Benign Lung Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Brain Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cervix Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Colon Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Colon Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Colorectal Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Endometrial Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Gallbladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>High-Grade B-Cell Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Malignant Neoplasm Of Renal Pelvis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Metastatic Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Myelodysplastic Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Nasal Sinus Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oesophageal Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ovarian Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Rectal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Renal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Renal Oncocytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Skin Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma Of Lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma Of Skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thyroid Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Uterine Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered State Of Consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Brain Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Brain Stem Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Carotid Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Carotid Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Carotid Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cerebral Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cerebral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cerebral Small Vessel Ischaemic Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cervical Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dementia With Lewy Bodies</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Embolic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Generalised Tonic-Clonic Seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haemorrhage Intracranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hemianopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypercapnic Coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypertensive Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypokinesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypoxic-Ischaemic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intracranial Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ischaemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lumbar Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lumbosacral Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Neuromyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Postictal State</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Subarachnoid Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tarsal Tunnel Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tension Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thalamic Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Trigeminal Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vascular Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Breakage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Dislocation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Leakage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Loosening</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Device Physical Property Issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lead Dislodgement</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thrombosis In Device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol Withdrawal Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Completed Suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Delirium Tremens</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bladder Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bladder Outlet Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Calculus Bladder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Renal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Subcapsular Renal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urethral Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Endometrial Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Testicular Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vaginal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dyspnoea Exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Idiopathic Pulmonary Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lung Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Mediastinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pulmonary Congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pulmonary Mass</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Respiratory Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thoracic Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Decubitus Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ischaemic Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pyoderma Gangrenosum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Subcutaneous Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Aneurysm Repair</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Ankle Operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cardiac Pacemaker Insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Decompression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Cataract Operation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Coronary Endarterectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Drain Removal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hernia Repair</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hip Arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hip Surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Knee Arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Shoulder Arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Spinal Fusion Surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thoracic Cavity Drainage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Toe Amputation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Tooth Extraction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Transurethral Bladder Resection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Angiopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Aortic Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arterial Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arterial Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Artery Dissection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Femoral Artery Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Femoral Artery Dissection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haemodynamic Instability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypertensive Urgency</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypovolaemic Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Intermittent Claudication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Lymphorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Dissection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Peripheral Venous Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Shock Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Vasodilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="474" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="571" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="145" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Blood Loss Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="163" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="196" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="151" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block First Degree</sub_title>
                <counts group_id="E1" subjects_affected="115" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="119" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bundle Branch Block Left</sub_title>
                <counts group_id="E1" subjects_affected="246" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="141" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Bundle Branch Block Right</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="65" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="65" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="54" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="69" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="109" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="76" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="684"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="730"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="684"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Within 60 days of receipt Medtronic (MDT) will verify presence of Confidential Information (CI) &amp; won't censor or interfere with presentation/conclusions except to protect CI (other than Study Data) &amp; its rights in patentable or copyrightable materials, &amp; check technical accuracy of MDT data. If told by MDT that Publication contains CI or technical errors of MDT data, PI will make requested changes before publishing/presenting. PI will delay publication up to 90 more days, if requested.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kristin Smith, Clinical Research Manager</name_or_title>
      <organization>Medtronic Structural Heart &amp; Aortic Clinical Research &amp; Medical Science</organization>
      <phone>763-526-3095</phone>
      <email>kristin.m.smith@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

